MedTrace Logo

Hungarian National Systemic Amyloidosis Registry

NCT07689331 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2026-07-08

No results posted yet for this study

Summary

This registry is an observational, multicenter, retrospective and prospective, non-pharmacological study designed to collect and analyze data from patients with systemic amyloidosis treated in inpatient and outpatient cardiology, hematology, nephrology, and neurology departments across Hungary. The registry was established in 2025.

Conditions

  • Systemic Amyloidosis
  • ATTR Amyloidosis
  • AL Amyloidosis
  • Amyloid Cardiomyopathy

Sponsors & Collaborators

  • Semmelweis University

    lead OTHER

Principal Investigators

  • Zoltan Pozsonyi, MD, PhD · Department of Internal Medicine and Hematology, Semmelweis University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-08
Primary Completion
2028-05-31
Completion
2028-05-31

Countries

  • Hungary

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07689331 on ClinicalTrials.gov